TITLE

Use of quantum dots in the development of assays for cancer biomarkers

AUTHOR(S)
Megan Wagner; Feng Li; Jingjing Li; Xing-Fang Li; Le, X.
PUB. DATE
August 2010
SOURCE
Analytical & Bioanalytical Chemistry;Aug2010, Vol. 397 Issue 8, p3213
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
Biomarker assays may be useful for screening and diagnosis of cancer if a set of molecular markers can be quantified and statistically differentiated between cancerous cells and healthy cells. Markers of disease are often present at very low concentrations, so methods capable of low detection limits are required. Quantum dots (QDs) are nanoparticles that are emerging as promising probes for ultrasensitive detection of cancer biomarkers. QDs attached to antibodies, aptamers, oligonucleotides, or peptides can be used to target cancer markers. Their fluorescent properties have enabled QDs to be used as labels for in-vitro assays to quantify biomarkers, and they have been investigated as in-vivo imaging agents. QDs can be used as donors in assays involving fluorescence resonance energy transfer (FRET), or as acceptors in bioluminescence resonance energy transfer (BRET). The nanoparticles are also capable of electrochemical detection and are potentially useful for “lab-on-a-chip” applications. Recent developments in silicon QDs, non-blinking QDs, and QDs with reduced-size and controlled-valence further make these QDs bioanalytically attractive because of their low toxicity, biocompatibility, high quantum yields, and diverse surface modification flexibility. The potential of multiplexed sensing using QDs with different wavelengths of emission is promising for simultaneous detection of multiple biomarkers of disease. [Figure not available: see fulltext.]
ACCESSION #
52532523

 

Related Articles

  • Multiplexed Quantum Dot Labeling of Activated c-Met Signaling in Castration-Resistant Human Prostate Cancer. Peizhen Hu; Chu, Gina C.-Y.; Guodong Zhu; Hua Yang; Luthringer, Daniel; Prins, Gail; Habib, Fouad; Yuzhuo Wang; Ruoxiang Wang; Chung, Leland W. K.; Zhau, Haiyen E. // PLoS ONE;2011, Vol. 6 Issue 12, p1 

    The potential application of multiplexed quantum dot labeling (MQDL) for cancer detection and prognosis and monitoring therapeutic responses has attracted the interests of bioengineers, pathologists and cancer biologists. Many published studies claim that MQDL is effective for cancer biomarker...

  • Quantum leaps.  // Nature Biotechnology;Mar2006, Vol. 24 Issue 3, p305 

    The article provides information on properties imagers for quantum dots. Compared to organic dyes, nanocrystals are 20 times brighter and orders of magnitude are more stable to photobleaching. According to a report, quantum dots could label cancer markers, actin and nuclear antigens inside...

  • Detection of small RNA molecules by a combination of branched rolling circle amplification and bioluminescent pyrophosphate assay. Mashimo, Yasumasa; Mie, Masayasu; Suzuki, Shigeya; Kobatake, Eiry // Analytical & Bioanalytical Chemistry;Nov2011, Vol. 401 Issue 1, p221 

    errant expression of miRNAs often correlates with various human diseases. Therefore, miRNAs have been focused as disease biomarkers. Here, a novel application of a bioluminescence (BL) assay for small RNA quantification is described. The assay is based on detecting pyrophosphate (PPi) molecules...

  • A Theranostic 'SMART' Aptamer for Targeted Therapy of Prostate Cancer. de Franciscis, Vittorio // Molecular Therapy;Nov2014, Vol. 22 Issue 11, p1886 

    The author discusses aspects of the preclinical characterization of a nucleic acid aptamer, a single-chain oligonucleotides, molecule as safe and effective alternative for the therapy of prostate cancer. Topics explore include the characteristics of aptamer, the current standard therapies for...

  • Functionalization of nc-Si/SiO semiconductor quantum dots by oligonucleotides. Bayramov, F.; Poloskin, E.; Kornev, A.; Chernev, A.; Toporov, V.; Dubina, M.; Röder, C.; Sprung, C.; Lipsanen, H.; Bairamov, B. // Semiconductors;Nov2014, Vol. 48 Issue 11, p1485 

    nc-Si/SiO crystalline semiconductor quantum dots are very attractive as fluorescent labels for developing biosensors integrated with biomedical materials due to their unique physical properties in the visible region of the spectrum. We report on the functionalization of such nanostructures by...

  • On-chip silicon-based active photonic molecules by complete photonic bandgap light confinement. Bo Qian; Kunji Chen; San Chen; Wei Li; Xiangao Zhang; Jun Xu; Xinfan Huang; Lorenzo Pavesi; Chunping Jiang // Applied Physics Letters;7/18/2011, Vol. 99 Issue 3, p034105 

    We demonstrate an on-chip silicon-based active photonic molecule (PM) structures formed by two coupled photonic quantum dots with complete photonic bandgap (PBG) light confinement. The photonic quantum dots are grown by conformal deposition of amorphous silicon nitride multilayers on patterned...

  • Imaging biomarkers of inflammation in situ with fun ctionalized quantum dots in the dextran sodium sulfate (DSS) model of mouse colitis. A. Karwa; E. Papazoglou; K. Pourrezaei; S. Tyagi; S. Murthy // Inflammation Research;Dec2007, Vol. 56 Issue 12, p502 

    Abstract. Objective and design:  Myeloperoxidase (MPO) and proinflammatory cytokines play an important role in the development of inflammation. These markers are generally measured using tedious ELISA procedures. In this study, a novel technique utilizing antibody conjugated quantum dot...

  • Circulating tumor cells may be alternative for biomarker assessment. Harris, Jason; Southall, Jennifer // Hem/Onc Today;10/25/2010, Vol. 11 Issue 20, p20 

    The article discusses research being done on the use of circulating tumor cells as a noninvasive alternative for biomarker assessment, which references a study by Siminder Kaur and colleagues presented at the American Association for Cancer Research (AACR) International Conference in Denver,...

  • New Breast-to-Brain Metastasis Signature. Breindl, Anette // BioWorld Today;4/15/2013, Vol. 24 Issue 71, p9 

    This article discusses a research paper on a set of biomarkers that identify metastasis-prone brain cancer cells, referencing a study published in the April 11, 2013 issue of "Science Tranlational Medicine".

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics